Huijun Deng
Finance Executive DirectorMs. Huijun Deng is Finance Executive Director of IMPACT Therapeutics, Inc. Ms. Deng joined the IMPACT Therapeutics, Inc. in May 2024. From September 1997 to January 1999, she worked at Guangzhou Jinma Power Equipment Group Investment Branch. From December 1999 to June 2008, she worked at Xi’an Janssen Pharmaceutical Co., Ltd. From June 2008 to June 2013, she served as the financial controller in Taigao Nutrition Technology (Beijing) Co., Ltd. From June 2013 to February 2019, she worked as the senior financial director in Hologic. She has worked as the managing director of Custom Orient Capital International Co., Ltd. From March 2022 to July 2023, she served as the finance director of Beijing Coyote Bioscience Co., Ltd. Ms. Deng obtained her bachelor’s degree in economics from the Central South University in the PRC July 1997; her master’s degree in professional accounting (MPAcc) from the Research Institute (currently known as Ministry of Finance of China, Institute of Fiscal Sciences) in the PRC in December 2007. Ms. Deng is a Fellow of the Chartered Institute of Management Accountants (FCMA), a member of CIMA (Chartered Institute of Management Accountants) and AICPA (American Institute of CPAs) and holds the Chartered Global Management Accountant (CGMA) designation.
Positions
- Company NameIMPACT Therapeutics, IncStock Code07630PositionFinance Executive Director
